Why ROCA Care
If you have an alteration in one of the BRCA genes, preventative surgery (removal of both ovaries and fallopian tubes) is the first recommended option to reduce your risk of developing ovarian cancer.
However, you may decide to delay such surgery, in order to complete your family, or to avoid early menopause. In such cases, ROCA Care may be a helpful option.
*At the earliest point after learning that you carry an alteration in one of the BRCA genes, you should seek advice and learn about your options to minimise the risk of late-stage ovarian cancer.
What is ROCA Care
ROCA Care is a comprehensive surveillance package using the ROCA Test. It is offered by expert clinicians, for women who have a confirmed alteration in the BRCA1 or BRCA2 gene. The ROCA Test is also the only test for surveillance with demonstrated accuracy, as assessed by NICE (CG241)
With patient safety at the forefront, ROCA Care gives you clinical support during your period of ROCA surveillance, with the opportunity to frequently re-visit the need for preventative surgery depending on your age, specific BRCA alteration, family planning and other factors.
The ROCA Care package
ROCA Care includes:
- all pre and post-test clinical consultations
- ROCA Testing
- Phlebotomy
- Reporting of results
The ROCA Test should NOT be used as an alternative to preventative surgery. Only if a you cannot undergo or have decided to defer preventative surgery, should you consider the ROCA Test.
Where to find ROCA Care
ROCA Care is currently offered at Clinics in Cardiff, and London.
Frequently Asked Questions
A: The ROCA Test is the only test for surveillance with demonstrated accuracy, as assessed by NICE (CG241) and uses your CA-125 measurements, establishing your baseline levels of CA-125 with other parameters such as age to reveal an individualized profile of change over time rather than relying on a single C
A-125 fixed cut-off value.
A: It is recommended that you have a ROCA test 3 times a year. If your results are not Normal, your clinician may recommend a repeat ROCA Test within the next six weeks. You may also be referred for a transvaginal ultrasound (TVUS) scan of your ovaries or other clinical assessment determined by your clinician.